21.03.2013 Views

11 Chap 11 (bc/d) - Pharmaceutical Press

11 Chap 11 (bc/d) - Pharmaceutical Press

11 Chap 11 (bc/d) - Pharmaceutical Press

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

208 <strong>Chap</strong>ter <strong>11</strong> • Formulation and physical properties of soft capsules<br />

in such a way as to reduce the tendency of propylene<br />

glycol to migrate, during production and on<br />

storage, by using it as a plasticizer component in<br />

the shell and adjusting the manufacturing conditions<br />

at the drums to reduce tackiness of the<br />

ribbons (Brox et al., 1993; Woo, 1997). An<br />

additional benefit of this approach is, that the<br />

amount of water required for dissolving and<br />

melting the gelatin may be reduced owing to the<br />

lower viscosity of propylene glycol compared to<br />

glycerol and sorbitol solutions, thus reducing the<br />

overall water exchange between shell and fill.<br />

The problems associated with the use of a<br />

volatile solvent such as ethanol are more difficult<br />

to solve. To prevent volatilisation of ethanol, the<br />

finished capsules have to be enclosed in a solventtight<br />

packaging material such as an aluminium<br />

blister. Moreover, replacement of glycerol by<br />

higher polyols such as xylitol, sorbitol, sorbitol/<br />

sorbitan blends and/or hydrogenated starch<br />

hydrolysates has been reported as an effective<br />

means of reducing the rate and extent of ethanol<br />

diffusion into the shell (Reich, 1996; Moreton and<br />

Armstrong, 1998). In certain cases, however, both<br />

approaches may not be sufficient to prevent fill<br />

deterioration, since ethanol diffusion cannot be<br />

fully prevented. Thus, for a microemulsion preconcentrate<br />

formulation that is very sensitive to<br />

the co-solvent concentration, the only way to<br />

overcome the problem at present, is the use of a<br />

co-solvent other than ethanol, that is not volatile<br />

and does not show any diffusion into the capsule<br />

shell. For ciclosporin microemulsion preconcentrate<br />

soft capsules, such approaches have been<br />

filed in two patents, namely a European Patent<br />

Application (Woo, 1995) describing the use of<br />

dimethylisosorbide and a US Patent Application<br />

(Shin et al., 2000) that describes the use of a<br />

microemulsion preconcentrate containing a<br />

lipophilic instead of a hydrophilic co-solvent.<br />

Post-treatments and coatings<br />

Soft gelatin capsules may be post-treated after production<br />

or coated to improve product stability, to<br />

modify the dissolution rate and to enable enteric<br />

capsules to be produced. Several patents have<br />

been filed describing the use of protective coatings<br />

to overcome the stability problems of soft<br />

capsules arising from the hygroscopic nature and<br />

heat sensitivity of the soft capsule shell. However,<br />

most of these attempts have failed in practice,<br />

since coating of soft capsules is not an easy task.<br />

The low surface roughness of soft capsule shells<br />

and the intrinsic insolubility of the shell components<br />

in organic solvents means that coatings<br />

applied as an organic solution usually do not<br />

adhere properly to the capsules, resulting in<br />

onion-like coatings of layers peeling off immediately<br />

after drying or on storage. Aqueous coatings,<br />

on the other hand, may result in capsule swelling,<br />

softening and/or sticking together, since water is<br />

acting as a plasticizer for the gelatin capsule shells.<br />

To balance the two extremes, emulsion-based<br />

formulations or solutions in a mixture of water<br />

and alcohol have been recommended (Osterwald<br />

et al., 1982). The technological approach of choice<br />

for soft capsules to be coated is using the fluidisedbed<br />

air-suspension technique.<br />

Capsules with modified dissolution characteristics,<br />

such as gastroresistant enteric soft gelatin<br />

capsules, have been described in the scientific<br />

and patent literature and can be achieved by<br />

adding gastroresistant, enteric-soluble polymers<br />

to the gelatin mass prior to capsule formation, or<br />

by aldehyde post-treatment or enteric coating of<br />

the dried capsules. All three attempts have their<br />

specific difficulties. For soft gelatin capsules produced<br />

by the rotary die process, the last two<br />

approaches are in practical use.<br />

Aldehyde post-treatment of soft gelatin capsules<br />

has been known for many years as a popular<br />

means to reduce their dissolution rate, i.e. the<br />

capsules take a long time to dissolve and have left<br />

the stomach before this occurs. Formaldehyde<br />

has been described to cross-link effectively soft<br />

capsules to render them gastroresistant. Since<br />

safety questions have been raised about the<br />

presence of trace amounts of formaldehyde in<br />

foods and pharmaceuticals, the use of aldehydes<br />

without health concerns such as aldoses have<br />

been claimed in a patent (Fischer, 1986) and are<br />

actually used. The major disadvantage of any<br />

aldehyde treatment of soft gelatin capsules is that<br />

cross-linking can continue on storage. Alternatively,<br />

soft gelatin capsules may be coated with a<br />

gastroresistant, enteric-soluble polymer. Owing<br />

to the aforementioned difficulties associated with<br />

organic and aqueous soft capsule coating, a

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!